Cargando…

Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides

[Image: see text] This study sought to evaluate the impact of multiple negative charges on blood clearance kinetics and biodistribution properties of (99m)Tc-labeled RGD peptide dimers. Bioconjugates HYNIC-P6G-RGD(2) and HYNIC-P6D-RGD(2) were prepared by reacting P6G-RGD(2) and P6D-RGD(2), respectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yong, Ji, Shundong, Liu, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166031/
https://www.ncbi.nlm.nih.gov/pubmed/25144854
http://dx.doi.org/10.1021/bc500309r
_version_ 1782335190572466176
author Yang, Yong
Ji, Shundong
Liu, Shuang
author_facet Yang, Yong
Ji, Shundong
Liu, Shuang
author_sort Yang, Yong
collection PubMed
description [Image: see text] This study sought to evaluate the impact of multiple negative charges on blood clearance kinetics and biodistribution properties of (99m)Tc-labeled RGD peptide dimers. Bioconjugates HYNIC-P6G-RGD(2) and HYNIC-P6D-RGD(2) were prepared by reacting P6G-RGD(2) and P6D-RGD(2), respectively, with excess HYNIC-OSu in the presence of diisopropylethylamine. Their IC(50) values were determined to be 31 ± 5 and 41 ± 6 nM, respectively, against (125)I-echistatin bound to U87MG glioma cells in a whole-cell displacement assay. Complexes [(99m)Tc(HYNIC-P6G-RGD(2))(tricine)(TPPTS)] ((99m)Tc-P6G-RGD(2)) and [(99m)Tc(HYNIC-P6D-RGD(2))(tricine)(TPPTS)] ((99m)Tc-P6D-RGD(2)) were prepared in high radiochemical purity (RCP > 95%) and specific activity (37–110 GBq/μmol). They were evaluated in athymic nude mice bearing U87MG glioma xenografts for their biodistribution. The most significant difference between (99m)Tc-P6D-RGD(2) and (99m)Tc-P6G-RGD(2) was their blood radioactivity levels and tumor uptake. The initial blood radioactivity level for (99m)Tc-P6D-RGD(2) (4.71 ± 1.00%ID/g) was ∼5× higher than that of (99m)Tc-P6G-RGD(2) (0.88 ± 0.05%ID/g), but this difference disappeared at 60 min p.i. (99m)Tc-P6D-RGD(2) had much lower tumor uptake (2.20–3.11%ID/g) than (99m)Tc-P6G-RGD(2) (7.82–9.27%ID/g) over a 2 h period. Since HYNIC-P6D-RGD(2) and HYNIC-P6G-RGD(2) shared a similar integrin α(v)β(3) binding affinity (41 ± 6 nM versus 31 ± 5 nM), the difference in their blood activity and tumor uptake is most likely related to the nine negative charges and high protein binding of (99m)Tc-P6D-RGD(2). Despite its low uptake in U87MG tumors, the tumor uptake of (99m)Tc-P6D-RGD(2) was integrin α(v)β(3)-specific. SPECT/CT studies were performed using (99m)Tc-P6G-RGD(2) in athymic nude mice bearing U87MG glioma and MDA-MB-231 breast cancer xenografts. The SPECT/CT data demonstrated the tumor-targeting capability of (99m)Tc-P6G-RGD(2), and its tumor uptake depends on the integrin α(v)β(3) expression levels on tumor cells and neovasculature. It was concluded that the multiple negative charges have a significant impact on the blood clearance kinetics and tumor uptake of (99m)Tc-labeled dimeric cyclic RGD peptides.
format Online
Article
Text
id pubmed-4166031
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-41660312015-08-11 Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides Yang, Yong Ji, Shundong Liu, Shuang Bioconjug Chem [Image: see text] This study sought to evaluate the impact of multiple negative charges on blood clearance kinetics and biodistribution properties of (99m)Tc-labeled RGD peptide dimers. Bioconjugates HYNIC-P6G-RGD(2) and HYNIC-P6D-RGD(2) were prepared by reacting P6G-RGD(2) and P6D-RGD(2), respectively, with excess HYNIC-OSu in the presence of diisopropylethylamine. Their IC(50) values were determined to be 31 ± 5 and 41 ± 6 nM, respectively, against (125)I-echistatin bound to U87MG glioma cells in a whole-cell displacement assay. Complexes [(99m)Tc(HYNIC-P6G-RGD(2))(tricine)(TPPTS)] ((99m)Tc-P6G-RGD(2)) and [(99m)Tc(HYNIC-P6D-RGD(2))(tricine)(TPPTS)] ((99m)Tc-P6D-RGD(2)) were prepared in high radiochemical purity (RCP > 95%) and specific activity (37–110 GBq/μmol). They were evaluated in athymic nude mice bearing U87MG glioma xenografts for their biodistribution. The most significant difference between (99m)Tc-P6D-RGD(2) and (99m)Tc-P6G-RGD(2) was their blood radioactivity levels and tumor uptake. The initial blood radioactivity level for (99m)Tc-P6D-RGD(2) (4.71 ± 1.00%ID/g) was ∼5× higher than that of (99m)Tc-P6G-RGD(2) (0.88 ± 0.05%ID/g), but this difference disappeared at 60 min p.i. (99m)Tc-P6D-RGD(2) had much lower tumor uptake (2.20–3.11%ID/g) than (99m)Tc-P6G-RGD(2) (7.82–9.27%ID/g) over a 2 h period. Since HYNIC-P6D-RGD(2) and HYNIC-P6G-RGD(2) shared a similar integrin α(v)β(3) binding affinity (41 ± 6 nM versus 31 ± 5 nM), the difference in their blood activity and tumor uptake is most likely related to the nine negative charges and high protein binding of (99m)Tc-P6D-RGD(2). Despite its low uptake in U87MG tumors, the tumor uptake of (99m)Tc-P6D-RGD(2) was integrin α(v)β(3)-specific. SPECT/CT studies were performed using (99m)Tc-P6G-RGD(2) in athymic nude mice bearing U87MG glioma and MDA-MB-231 breast cancer xenografts. The SPECT/CT data demonstrated the tumor-targeting capability of (99m)Tc-P6G-RGD(2), and its tumor uptake depends on the integrin α(v)β(3) expression levels on tumor cells and neovasculature. It was concluded that the multiple negative charges have a significant impact on the blood clearance kinetics and tumor uptake of (99m)Tc-labeled dimeric cyclic RGD peptides. American Chemical Society 2014-08-11 2014-09-17 /pmc/articles/PMC4166031/ /pubmed/25144854 http://dx.doi.org/10.1021/bc500309r Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
spellingShingle Yang, Yong
Ji, Shundong
Liu, Shuang
Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides
title Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides
title_full Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides
title_fullStr Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides
title_full_unstemmed Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides
title_short Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides
title_sort impact of multiple negative charges on blood clearance and biodistribution characteristics of (99m)tc-labeled dimeric cyclic rgd peptides
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166031/
https://www.ncbi.nlm.nih.gov/pubmed/25144854
http://dx.doi.org/10.1021/bc500309r
work_keys_str_mv AT yangyong impactofmultiplenegativechargesonbloodclearanceandbiodistributioncharacteristicsof99mtclabeleddimericcyclicrgdpeptides
AT jishundong impactofmultiplenegativechargesonbloodclearanceandbiodistributioncharacteristicsof99mtclabeleddimericcyclicrgdpeptides
AT liushuang impactofmultiplenegativechargesonbloodclearanceandbiodistributioncharacteristicsof99mtclabeleddimericcyclicrgdpeptides